A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer
Titel:
A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer
Auteur:
Masuda, N. Higaki, K. Takano, T. Matsunami, N. Morimoto, T. Ohtani, S. Mizutani, M. Miyamoto, T. Kuroi, K. Ohno, S. Morita, S. Toi, M.